Nausea emerged in nearly four in ten people at higher doses in large studies, along with constipation and diarrhea
When we talk to a customer, the first question we ask is, "What are important outcomes to you?" This decisioning really sits on a continuum, and there is a continuum between high utilization and access of GLP-1s and overall weight-loss care and cost control
A suggested mechanism involves prolonged GIPR agonism causing receptor degradation, reducing sustained GIP signalling and, when combined with GLP-1R agonism, causing increased weight loss ( The GLP-1R has itself several LoF variants including R380C, shown by two independent groups to have normal surface expression but reduced affinity for Exenatide (Wootten et al., 2016
Protecting neural health
Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications. Current Neuropharmacology
Recalls & Warnings March 28, 2014 Nutrition Bars Recalled Due to Allergen Risk On March 27, 2014, Clif Bar & Company issued a voluntary recall of a small number of 15-count boxes of Chocolate Chunk LUNA Bars because they contain undeclared macadamia nut butter